Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan D Manning

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|August 21, 2014
Molecular basis of giant cells in tuberous sclerosis complexDavid J Kwiatkowski, Brendan D Manning
Cancer Research|October 2, 2021
Cancer Signaling Drives Cancer Metabolism: AKT and the Warburg EffectAaron M Hosios, Brendan D Manning
Trends in Biochemical Sciences|November 11, 2003
Rheb fills a GAP between TSC and TORBrendan D Manning, Lewis C Cantley
Cell|March 26, 2016
CASTORing New Light on Amino Acid SensingJames E Hughes Hallett, Brendan D Manning
EMBO Reports|February 13, 2013
The multifaceted role of mTORC1 in the control of lipid metabolismStéphane J H Ricoult, Brendan D Manning
Cancer Cell|October 31, 2003
Targeting the PI3K-Akt pathway in human cancer: rationale and promiseJi Luo, Brendan D Manning, Lewis C Cantley
Science Signaling|July 8, 2025
Evolution of growth factor signaling to the TSC complex to regulate mTORC1Kun Wang, Sophie E Lockwood, Brendan D Manning
Molecular and Cellular Biology|September 2, 2009
Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1Christian C Dibble, John M Asara, Brendan D Manning
Cancer Research|July 16, 2009
Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressorsJingxiang Huang, Shulin Wu, Chin-Lee Wu, et al.
Molecular and Cellular Biology|April 16, 2008
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2Jingxiang Huang, Christian C Dibble, Mika Matsuzaki, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|August 21, 2014
Molecular basis of giant cells in tuberous sclerosis complexDavid J Kwiatkowski, Brendan D Manning
Cancer Research|October 2, 2021
Cancer Signaling Drives Cancer Metabolism: AKT and the Warburg EffectAaron M Hosios, Brendan D Manning
Trends in Biochemical Sciences|November 11, 2003
Rheb fills a GAP between TSC and TORBrendan D Manning, Lewis C Cantley
Cell|March 26, 2016
CASTORing New Light on Amino Acid SensingJames E Hughes Hallett, Brendan D Manning
EMBO Reports|February 13, 2013
The multifaceted role of mTORC1 in the control of lipid metabolismStéphane J H Ricoult, Brendan D Manning
Cancer Cell|October 31, 2003
Targeting the PI3K-Akt pathway in human cancer: rationale and promiseJi Luo, Brendan D Manning, Lewis C Cantley
Science Signaling|July 8, 2025
Evolution of growth factor signaling to the TSC complex to regulate mTORC1Kun Wang, Sophie E Lockwood, Brendan D Manning
Molecular and Cellular Biology|September 2, 2009
Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1Christian C Dibble, John M Asara, Brendan D Manning
Cancer Research|July 16, 2009
Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressorsJingxiang Huang, Shulin Wu, Chin-Lee Wu, et al.
Molecular and Cellular Biology|April 16, 2008
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2Jingxiang Huang, Christian C Dibble, Mika Matsuzaki, et al.
Pageof 11